🔎 Trials Near Me

Akèy › Artrit Rematoid › Texas

Etid klinik pou Artrit Rematoid nan Texas

16 etid pou Artrit Rematoid ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

RA-PRO PRAGMATIC TRIAL

  • Heritage Rheumatology and Arthritis Care, Colleyville
  • Southwest Medical Center, Dallas
  • Texas Arthritis Center, PA, El Paso
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT04692493

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • ak 2 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

  • Tekton Research - West Gate /ID# 272270, Austin
  • Trinity Universal Research Associates - Carrollton /ID# 272577, Carrollton
  • Arthritis Care Of Texas /ID# 277961, Corpus Christi
  • ak 11 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06972446

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

  • Precision Comprehensive Clinical Research Solutions, Colleyville
  • Accurate Clinical Management, Houston
  • DM Clinical Research, Tomball
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07137598

An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

  • Accurate Clinical Management LLC, Houston
  • DM Clinical Research, Tomball
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07620392

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

  • Research Site, Allen
  • Research Site, Mesquite
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 18, 2026 · NCT07201558

Phase 1b/2 Study of IV Sarilumab in Adult With RA

  • ClinRx Research - Plano- Site Number : 8400015, Plano
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07704580

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

  • Nkarta Investigational Site, Dallas
  • Nkarta Investigational Site, Houston
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  • Artiva Investigational Site Arlington, Arlington
  • Artiva Investigational Site Bellaire, Bellaire
  • Artiva Investigational Site Irving, Irving
  • ak 4 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06991114

Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis

  • Precision Comprehensive Clinical Research Solutions, Colleyville
  • Rheumatology Associates, Dallas
  • Precision Comprehensive Clinical Research Solutions, Irving
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07293871

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

  • Research Site, Austin
  • Research Site, Baytown
  • Research Site, Houston
  • ak 3 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT07276581

R-2487 in Patients With Rheumatoid Arthritis

  • Prolato Clinical Research Center, Houston
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Jun 12, 2026 · NCT05961592

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

  • M D Anderson Cancer Center, Houston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT04751396

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

  • The University of Texas MD Anderson Cancer Center, Houston
Ap rekriteEtid obsèvasyon
Laj 18 a 71 · Tout sèks · Mizajou Apr 16, 2026 · NCT07123038

ConsideRAte Study - Splenic Stimulation for RA

  • Arthritis & Rheumatology Institute, Allen
  • St. David's Healthcare, Austin
  • Tekton Research, Austin
  • ak 1 plis
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou May 22, 2024 · NCT05003310

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.